Frontlight ResearchEarly access
Ovarian cancer trials in Belarus
1 trial · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peoplePARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer
- Where
- Minsk
- Age
- 18 years to 75 years
- People
- 120
- Run by
- N.N. Alexandrov National Cancer Centre
See details and how to joinNCT07472140